Eli Lilly CEO reveals latest developments in Alzheimer's research
Eli Lilly & Company Chairman and CEO Dave Ricks sheds light on growth and success, the increase in weight loss drug popularity and research into Alzheimer's.
It's a 'pretty serious' flu season: Dr. Marc Siegel
Fox News senior medical analyst Dr. Marc Siegel joins 'Varney & Co.' to discuss the flu and COVID-19 season as well as a study linking light pollution to Alzheimer's.
FDA approves marketing for new Alzheimer's early detection test
The Lumipulse G β-Amyloid Ratio (1-42/1-40) test is available at clinical laboratories nationwide for adult patients aged 55 years and older who are presenting with cognitive impairment and being evaluated for Alzheimer’s disease and other causes of cognitive decline.